Support Tools for Treatment Decisions
Making Sense of Your Melanoma Treatment Options
After a melanoma diagnosis, you may face a flood of information, testing recommendations, and—especially in later stages—a range of treatment options. To help you and your healthcare team make the best choices for your care, it’s essential to understand your risk of recurrence, explore all available treatments, and learn the details of each option.
To support you in this process, AIM has developed a set of practical, patient-focused tools designed to guide and empower you every step of the way.
Stage IV Melanoma Treatment Options: Making the Decision That’s Right for You
If you or a loved one has been diagnosed with Stage IV melanoma or is undergoing evaluation, this guide is here to support you. It provides valuable insights to help you and your oncology team explore treatment options and navigate the key factors involved in choosing the best path forward. With this resource, you can work together to carefully assess your choices and make an informed decision that aligns with your needs and priorities.
Options for Stage III Melanoma: Making the Decision That’s Right for You
AIM’s guide, Options for Stage III Melanoma: Making the Decision That’s Right for You, is written for Stage III patients, to help explain what treatment options are available. The booklet begins by providing an in-depth discussion of why Stage III patients are at high risk for a melanoma recurrence and why treatment should be considered. It continues with a discussion of the treatment options available for Stage III patients, followed by information about how the drugs work and their side effects. The booklet also discusses other considerations such as fertility, finances, and drug administration. Finally, this guide provides a chart to help weigh the different options and, ultimately, make the treatment decision.
Options for Stage II Melanoma: Making the Decision That’s Right for You
To provide you or your loved one with a deeper understanding of Stage II melanoma and to explore the benefits and risks of adjuvant therapy versus active surveillance, we’ve invited two melanoma experts to share their insights in an engaging discussion.
Dr. Geoffrey Lim, a dermatologic surgeon at SkinMed Institute in Lone Tree, Colorado, recently conducted an insightful interview with Dr. Jason Luke, Associate Professor of Medicine at the University of Pittsburgh Medical Center and a renowned medical oncologist. Dr. Luke, one of the key authors behind a pivotal study on adjuvant therapy, shared his expertise on Stage II melanoma. Their discussion explored frequently asked questions about Stage II melanoma, which patients may qualify for adjuvant therapy, and the pros and cons of pursuing adjuvant therapy versus opting for active surveillance. This comprehensive resource is designed to assist you, your loved ones, and your oncology care team in making well-informed decisions about the next steps following surgery.
Is Immunotherapy Working for Me? What a Blood Draw Can Reveal
A new blood test is now available for Stage IV patients, designed to evaluate whether immunotherapy is effectively working. This can play a crucial role in guiding treatment decisions. This booklet provides a clear explanation of how the test works, real-world examples of how it can inform treatment choices, and a helpful FAQ section addressing common financial concerns.
BRAF in Melanoma: Answering Questions, Addressing Misconceptions
This booklet is designed for patients with Stage III and IV conditions, as well as select Stage II patients. It provides a clear explanation of BRAF, its significance, and the importance of knowing your BRAF status. Additionally, it details how the BRAF test is conducted and how your results can guide treatment decisions.
Side Effect Management Guides
In partnership with leading melanoma oncology experts, AIM has developed comprehensive and up-to-date information on the side effects of commonly used melanoma treatments currently approved by the U.S. Food and Drug Administration.
Download or flip through the following patient-friendly side melanoma side effect management guides: